← Leaderboards
Alexander Wanless Smith
Icahn School Of Medicine At Mount Sinai
$1,372,140
Attributed
$2,174,218
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,174,218 · 4
By mechanism
U01$1,002,597 · 1
R00$746,999 · 1
K99$343,008 · 1
F32$81,614 · 1
Top collaborators
- Christine Cheng1 shared
- Dongjun Chung1 shared
- Giordano De Guglielmo1 shared
- Abraham A Palmer1 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Paul J Kenny$51,539,568
- Mariana Gross Figueiro$26,395,173
- Tony Yuen$10,254,831
- Se-Min Kim$2,209,838
- Mone Zaidi$25,912,145
Others in their field
Other Emerging Leaders on “Data Set”
- Joel A Lipkin · Four Points Technology, Llc$182,936,915
- Terry Drinkwine · Carahsoft Technology Corporation$93,011,563
- Leonard Freedman · Leidos Biomedical Research, Inc.$92,966,200
- April Brinkoetter · Hungry Heart Media, Inc.$59,802,265
- Martha Hering · Westat, Inc.$57,098,843
- Susan Abushakra · Alzheon, Inc.$47,265,244
Research focus
Data SetMolecularBehaviorGeneticGenesSelf AdministrationRelapseRattusProteinsCellsOpiate AddictionOxycodonePropertyAnimalsPharmaceutical PreparationsMouse ModelBrainNeurobiologyGene TargetingMessenger RnaBioinformaticsBrain RegionAbstinenceIntake
Grant awards (8)
The Genetic Basis of Opioid Dependence Vulnerablility in a Rodent Model$1,002,597
U01 · FY2025 · DA
Discovery of novel pharmacotherapeutic targets for opioid addiction$248,999
R00 · FY2024 · DA · contact PI
Discovery of novel pharmacotherapeutic targets for opioid addiction$249,000
R00 · FY2023 · DA · contact PI
Discovery of novel pharmacotherapeutic targets for opioid addiction$249,000
R00 · FY2022 · DA · contact PI
Discovery of novel pharmacotherapeutic targets for opioid addiction$171,504
K99 · FY2021 · DA · contact PI
Discovery of novel pharmacotherapeutic targets for opioid addiction$171,504
K99 · FY2020 · DA · contact PI
Role of microRNA-212 in striatal plasticity underlying cocaine addiction$24,920
F32 · FY2018 · DA · contact PI
Role of microRNA-212 in striatal plasticity underlying cocaine addiction$56,694
F32 · FY2017 · DA · contact PI